Jorge Lopez, MD
Neurology with Special Qualifications in Child Neurology · Huntington, WVNPI 1982652657
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $42,978 of the $54,230 with a category attached, or 79.3%. Lilly USA, LLC accounts for 72.3% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2020 at $23,820 and has fallen 98.1% since, to $448 in 2025.
Across 256 payments — averaging $211.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$39K
- AbbVie$8K
- Teva Pharmaceuticals USA, Inc.$6K
- Pfizer$99
- Amgen$73
- Neurelis, Inc.$62
- plus $275 from 10 others
Across 29 payments — averaging $3448.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- H. Lundbeck A S$51K
- Eli Lilly$28K
- Upsher-smith Laboratories LLC$21K
What the payments were for
- Consulting fees$4,5138%
- Speaking & faculty fees$42,97879%
- Travel & lodging$3,0856%
- Food & beverage$3,5567%
- Education$980%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 86 | $39,181 |
| AbbVie(2 entities) | 140 | $8,383 |
| Teva Pharmaceuticals USA, Inc. | 6 | $6,157 |
| Pfizer | 4 | $99 |
| Amgen(2 entities) | 4 | $73 |
| Neurelis, Inc. | 4 | $62 |
| AstraZeneca | 1 | $62 |
| UCB, Inc. | 1 | $38 |
| Novo Nordisk | 2 | $36 |
| Upsher-smith Laboratories LLC | 1 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Merz Pharmaceuticals, LLC | 1 | $21 |
| Medtronic | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Argenx US, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neurology with special qualifications in child neurology providers in West Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 42 | $54,572 |
| Emgality PenGalcanezumab-Gnlm | 19 | $14,235 |
| Sumatriptan Succinate | 64 | $1,983 |
| RizatriptanRizatriptan Benzoate | 37 | $725 |
| Naratriptan Hcl | 19 | $681 |
| Topiramate | 28 | $443 |
| Amitriptyline Hcl | 16 | $138 |
| Propranolol Hcl | 13 | $98 |
| Atorvastatin Calcium | 13 | $79 |
| Ibuprofen | 11 | $25 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $99 | $54,57242 claims |
| Upsher-smith Laboratories LLCTopiramate | $29 | $44328 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few neurology with special qualifications in child neurology providers in West Virginiaon file to place this against a meaningful peer group, so we don't.
Other neurology with special qualifications in child neurology in Huntington
- Paul KnowlesHuntington$3K
- Mary PayneHuntington$899
- Margaret JaynesMorgantown$4K
- Wadih BaajourMorgantown$3K
- John MagruderMorgantown$766
- Surya GuptaSouth Charleston$49
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.